Genes, mos: Clinical Trials

3 trials of Genes, mos, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 withdrawn. 3 Phase 1, 3 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 13Completed 2, Withdrawn 1
Phase 23Completed 2, Withdrawn 1

Follow Genes, mos: new trials by email Literature Review of Genes, mos trials Research Report on Genes, mos

Trials (filtered) newest first · largest first

All 3 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Treatment of Degenerative Disc Disease With Allogenic Mesenchymal Stem Cells (MSV)
Allogenic Mesenchymal Stromal Cells, Mepivacaine - Degenerative Disc Disease, Intervertebral Disc Disease
Phase 1 / Phase 2CompletedRed de Terapia Celular242013-06-212024-04-29
Lumbar Degenerative Disc Disease Treatment With Bone Marrow Autologous Mesenchymal Stem Cells (MSV)
Autologous bone marrow mesenchymal stem cells - Degenerative Disc Disease
Phase 1 / Phase 2WithdrawnRed de Terapia Celular2011-06-012015-05-12
Treatment of Knee Osteoarthritis With Autologous Mesenchymal Stem Cells
Autologous bone marrow mesenchymal stem cells (MSV) - Osteoarthritis, Knee, Knee Degenerative Disease
Phase 1 / Phase 2CompletedRed de Terapia Celular122010-05-012015-01-15

Conditions studied

Intervertebral Disc Degeneration (2)  ·  Low Back Pain (2)  ·  Musculoskeletal Diseases (2)  ·  Intervertebral disc disease (1)  ·  Osteoarthritis (1)  ·  Osteoarthritis, Knee (1)

Sponsors

Red de Terapia Celular (3)

Countries

Spain (2)

Top investigators

Ana Sanchez, MD, PhD (2)  ·  Javier Garcia-Sancho, MD, PhD (2)  ·  David C Noriega, MD, PhD (1)  ·  FRancisco Ardura, MD, PhD (1)  ·  Luis Orozco, MD, PhD (1)  ·  Robert Soler, MD (1)

Results publications

PMID 23680930, PMID 24887752, PMID 27661661